TrialFinder  /  Landscape Report CEREBELLAR ATAXIA  ·  2026-09-02 Revasser  /  revasserkernel.com
Landscape Report TrialFinder
SOURCE  ClinicalTrials.gov API v2
GENERATED  2026-09-02
VERSION  v1
SAMPLE  100 of 534 studies

cerebellar ataxia

The cerebellar ataxia clinical trial landscape includes 534 actively recruiting trials. Semantic expansion identified 452 additional trials beyond exact-match search, representing a 551.2% discovery lift across related conditions and therapeutic approaches.

Recruiting
534
active trials
Expansion Lift
+551.2%
452 additional trials
Top Sponsor
Johns Hopkins University
3 trials
Dominant Phase
NA
69 of 103 sampled
Pipeline Overview
Phase Distribution
NA
69
Early I
2
Phase 1
6
Phase 2
5
Phase 3
1
Phase 4
1
Other
19
Therapeutic Modalities
DEVICE
56
OTHER
50
BEHAVIORAL
27
DRUG
14
PROCEDURE
8
DIAGNOSTIC_TEST
2
Recruiting vs. Completed (2yr)
Recruiting
534
Completed
279
Competitive Landscape
Sponsor Classification
93%
7%
OTHER (27)
INDUSTRY (2)
Top Sponsors
SponsorTrialsClass
Johns Hopkins University3OTHER
Indiana University3OTHER
Washington University School of Medicine2OTHER
Chang Gung University2OTHER
University of Minnesota2OTHER
Chang Gung Memorial Hospital2OTHER
Massachusetts Eye and Ear Infirmary2OTHER
Universidade Federal de Pernambuco2OTHER
University of Texas Southwestern Medical Center2OTHER
Riphah International University2OTHER
I.R.C.C.S. Fondazione Santa Lucia2OTHER
Biogen2INDUSTRY
China Medical University Hospital1OTHER
Hacettepe University1OTHER
Chinese University of Hong Kong1OTHER
Geographic Distribution
Top U.S. States by Trial Density
StateTrialsTop City
Massachusetts9Boston
Texas9Dallas
Maryland7Baltimore
Florida5Gainesville
Minnesota4Minneapolis
Pennsylvania4Philadelphia
California3Los Angeles
North Carolina3Chapel Hill
Indiana3Indianapolis
Missouri2St Louis
Ohio2Cleveland
Georgia2Atlanta
New Jersey2Newark
New York2New York
Virginia2Manassas
Illinois2Chicago
Michigan1Ann Arbor
Wisconsin1Madison
Tennessee1Nashville
Colorado1Aurora
Expansion Intelligence
+551.2%
Discovery lift — trials found by semantic expansion that exact-match search misses entirely. This is the gap competitors don't see.
1
Exact
1
Parent
1
Region
4
Related
4
Comorbid
3
Therapeutic
Top Expansion Terms
  • ataxia Parent
  • cerebellar Region
  • spinocerebellar ataxia Related
  • Friedreich ataxia Related
  • episodic ataxia Related
  • ataxia telangiectasia Related
  • dysarthria Comorbid
  • nystagmus Comorbid
  • gait disorder Comorbid
  • tremor Comorbid

These terms are curated from clinical literature — not generated by a language model. Each captures trials that use variant nomenclature for the same underlying condition or therapeutic area.

Key Findings
What This Landscape Means for cerebellar ataxia
high
Standard searches miss 551% of relevant trials for cerebellar ataxia — semantic expansion across related conditions and therapeutic approaches is essential for complete landscape visibility.
452 additional trials found via expansion vs 82 exact matches
high
Phase 2 volume (5) significantly exceeds Phase 3 (1), indicating a pipeline bottleneck — most candidates are 2-4 years from potential approval.
Phase 2/Phase 3 ratio: 5.0x
Next Steps
Take Action on This Intelligence
//
Stay Current
Get alerted when new trials open for cerebellar ataxia and related conditions. Free tier monitors 1 condition weekly.
Set Up Alerts
[+]
Research Portal
Deploy this intelligence as your organization's permanent research hub — auto-updating, branded, zero hosting cost.
From $497
{<}
API Access
Integrate trial intelligence into your own tools. Full expansion engine, landscape analytics, real-time data.
View Plans
Top Recruiting Trials
20 actively recruiting studies
Exploring the Possible Beneficial Impact of Non-invasive and Invasive Neuromodulation on Freezing of Gait in Parkinson's Disease During Different Ambulatory Complexities: An Electrophysiological and fMRI Study
China Medical University Hospital n=20 China Medical University Hospital/Neuro Depart Taichung
Intervention DEVICE: Transcranial direct current stimulation — A consecutive 5-days course of tDCS will be delivered. In treatment group, true stimulation will be administrated and sh...
Eligibility Ages 20 Years – 90 Years
Contact Chon-Haw Tsai, PHD · 8864-22052121 · 008079@tool.caaumed.org.tw
Motor Imagery and Action Observation for Gait Function in MS
Hacettepe University n=20 Hacettepe University, Faculty of Physical Therapy and Rehabilitation Ankara
Intervention BEHAVIORAL: Action Observation + Motor Imagery — Participants will watch videos showing walking actions and will be instructed to mentally simulate the movement.
Eligibility Ages 18 Years
Contact Merve Ünal, Res. Asst. · +905386582787 · merveunal.144@gmail.com
Hong Kong Spinocerebellar Ataxias Registry
Chinese University of Hong Kong n=300 Prince of Wales Hospital Hong Kong, Shatin
Intervention OTHER: no intervention — No intervention but clinical assessement for all recruited subjects
Eligibility Ages 18 Years – 90 Years
Contact Anne YY CHAN · (852) 3505 1855 · yychananne@gmail.com
Clinical Outcomes for Deep Brain Stimulation
Washington University School of Medicine n=1000 Washington University in St Louis St Louis, Missouri
Intervention DEVICE: Deep Brain Stimulation — High frequency electrical stimulation of deep brain nuclei for the treatment of movement disorders
Contact Mwiza Ushe, M.D. · 3143625262 · ushem@wustl.edu
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
The Cleveland Clinic n=186 Cleveland Clinic Foundation Cleveland, Ohio
Intervention DEVICE: Focused shockwave — Storz Duolith SD-1 (Storz Medical, Tagerwilen, Switzerland)
Eligibility Ages 40 Years, MALE only
Contact Petar Bajic · 216-444-1231 · bajicp@ccf.org
Visual Influences on Vestibular Adaptation
Emory University n=100 Emory Ophthalmology Clinics Atlanta, Georgia
Intervention DEVICE: StableEyes: Incremental Vestibulo-Ocular Reflex Adaptation (IVA) — IVA is delivered using the StableEyes device, which includes a lightweight head-mounted unit with inertial sensors and a...
Eligibility Ages 18 Years – 60 Years
Contact Colin R Grove, PT,DPT,PhD · (404) 712-8685 · colin.riess.grove@emory.edu
Mobile Application for Gait Training in Parkinson's Disease
Ege University n=52 Ege University Izmir, İzmir
Intervention DEVICE: Mobile Application (Auditory and Tactile Stimuli) — A smartphone application providing automated, patient-specific metronome sounds and tactile vibrations to support optima...
Eligibility Ages 60 Years – 80 Years
Contact Mehmet Özkeskin, Associate Professor · +905056631833 · mehmet.ozkeskin76@gmail.com
Cycling-Based Priming Coordination Training for Enhancing Ataxia Recovery and Brain Plasticity
Chang Gung University n=40 Chang Gung University Taoyuan
Intervention PROCEDURE: Cycling Training — Cycling combined with priming strategies to enhance motor learning tasks. Each session will last for 15 minutes, conduct...
Eligibility Ages 18 Years
Cerebellar Stimulation for Aphasia Rehabilitation
Johns Hopkins University n=60 Johns Hopkins Hospital Baltimore, Maryland
Intervention DEVICE: Cathodal Cerebellar tDCS — 2 mA of cathodal tDCS is induced between two 5cm X 5cm saline soaked sponges where the cathode sponge is placed on the r...
Eligibility Ages 18 Years – 99 Years
Contact Rajani Sebastian, PhD · 410-502-2445 · rsebast3@jhmi.edu
Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
Paradromics n=2 University of California, Davis Sacramento, California
Intervention DEVICE: Connexus Brain-Computer Interface — The Connexus Brain Computer Interface is an implantable brain-computer interface.
Eligibility Ages 22 Years – 75 Years
Contact Paradromics Clinical Team · (512) 559 4120 · clinical-team@paradromics.com
Deep Anterior Cerebellar Stimulation in Treatment of Poststroke Spasticity and Motor Function Impairment.
Jan Biziel University Hospital No 2 in Bydgoszcz n=12 Department of Neurosurgery and Neurology University Hospital nr 2 Collegium Medicum Nicolaus Copernicus University Bydgoszcz
Intervention PROCEDURE: Deep brain stimulation electrode implantation with an electrode target in the dentate nucleus — The intervention will involve implantation of a directional electrode with a target in the dentate nucleus of the cerebe...
Eligibility Ages 18 Years
Contact Paweł Sokal, Ph.D. · +48600954415 · pawel.sokal@cm.umk.pl
Wearable Sensory Prosthesis to Improve Coordination, Walking, and Physical Activity
RxFunction Inc. n=18 Brooks Rehabilitation Center Jacksonville, Florida
Intervention DEVICE: External, lower limb sensory prosthesis — Walkasins is an external, lower limb sensory prosthesis intended to replace part of the nerve function used for detectio...
Eligibility Ages 60 Years
Contact Dorian Rose, PT, MS, PhD, FAPTA · 352-273-8307 · research@rxfunction.com
Directional Bilateral Thalamic Patterned Stimulation (Chronos)
Alfonso Fasano n=15 Movement Disorders Centre - Toronto Western Hospital Toronto, Ontario
Intervention OTHER: DBS programing — The physician will utilize the Boston Scientific Chronos Clinician Programmer (software) to make adjustments to the Deep...
Eligibility Ages 18 Years – 85 Years
Gait Rehabilitation to Treat FastOA
University of North Carolina, Chapel Hill n=70 University of North Carolina at Chapel Hill Chapel Hill, North Carolina
Intervention BEHAVIORAL: Real-time gait biofeedback — The RTGBF interventions will include eighteen step gait training sessions. The intervention will gradually increase to 3...
Eligibility Ages 16 Years – 35 Years
Contact Natalia Favoreto, MS · 9199622025 · favoreto@med.unc.edu
Percept Transitions in FOG and PD
University of Minnesota n=36 University of Minnesota, Movement Disorders Lab Minneapolis, Minnesota
Intervention OTHER: OFF Parkinson's Medication(s) — Participants will be asked to withhold Parkinson's medications 12 hours prior to their testing visit (if extended-releas...
Eligibility Ages 21 Years – 75 Years
Contact Madison Aasen, MS · 612-505-8325 · aasen056@umn.edu
Impact of Force Control of Hip Abductor Muscles in Healthy Adults and Individuals With Parkinson's Disease
Chang Gung Memorial Hospital n=210 Chang Gung Memorial Hospital Taoyuan
Intervention OTHER: Age — We compare the young, middle-aged, and old groups
Eligibility Ages 20 Years – 85 Years
Contact Chu-Ling Yen · 886-3-2118800 · clyen@mail.cgu.edu.tw
Safety and Feasibility of TWIICE Rise - Phase 2
TWIICE n=15 Swiss Paraplegic Centre Nottwil Nottwil, Canton of Lucerne
Intervention DEVICE: TWIICE Rise — TWIICE Rise is a lower-limb overground robotic exoskeleton intended for patients with spinal cord injury (SCI). TWIICE ...
Eligibility Ages 18 Years – 70 Years
Contact Mario Widmer, PhD · +41 41 939 51 97 · mario.widmer@paraplegie.ch
The Effect of Mobile Robot Assisted Gait Training on Gait Performance in Chronic Patients With Impaired Gait Function After Burn Injury
Hangang Sacred Heart Hospital n=20 Hangang sacred heart hodpital Seoul
Intervention OTHER: wearable robot training — The wearable robot (WIRobotics Inc) is a wearable robot designed to provide assistive torque and resistive torque for hi...
Eligibility Ages 19 Years – 65 Years
Contact SO YOUNG JOO · 82-10-3234-9839 · anyany98@gmail.com
Explore the Impacts of One Session and Multiple Session Theta Burst Stimulation Over Cerebellum in Adults With Autism Spectrum Disorder
Chang Gung Memorial Hospital n=60 Chang Gung Memorial Hospital Taoyuan
Intervention DEVICE: Theta Burst Stimulation (TBS, an advanced variant of repetitive transcranial magnetic stimulation) — Participants will receive a single session of either iTBS or cTBS (600 pulses) targeting the right cerebellar Crus I/II....
Eligibility Ages 18 Years
Contact Hsing-Chang Ni, Ph.D · 88633281200 · alanni0918@yahoo.com.tw
NCT05216770 EARLY_PHASE1
Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor
Massachusetts Eye and Ear Infirmary n=165 Massachusetts Eye and Ear and University of California San Francisco Boston, Massachusetts
Intervention OTHER: Brain imaging — Brain images will be conducted with function MRI, magnetoencephalography (MEG), and electroencephalography (EEG) to iden...
Eligibility Ages 18 Years – 80 Years
Contact Kristina Simonyan, MD, PhD · 617-573-6016 · simonyan_lab@meei.harvard.edu